Leukemia - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Comparing Treatments for Chronic Myelogenous Leukemia
(Posted: 02/13/2007) - In this trial, doctors will compare the effectiveness of imatinib (Gleevec) at the standard dose versus an increased dose and against a new drug called dasatinib (Sprycel) as initial therapy for chronic myelogenous leukemia.
- Studying Chronic Graft-versus-Host Disease
(Posted: 07/18/2006) - In this study, researchers are interested in determining the natural history of chronic graft-versus-host disease and assessing biological factors that may predict outcomes associated with it.
- Studying Dyskeratosis Congenita
(Posted: 07/11/2006) - Persons with a rare disorder called dyskeratosis congenita (DC) tend to have a high risk of developing bone marrow failure, leukemia, or certain carcinomas. NCI is undertaking an intensive assessment of families with DC to learn more about how genes associated with it lead to cancer development and to identify new susceptibility genes for DC.
- Flavopiridol for Previously Treated Chronic Lymphocytic Leukemia
(Posted: 10/25/2005, Updated: 05/30/2006) - In this trial, researchers are testing a drug called flavopiridol (or alvocidib) in patients with relapsed chronic lymphocytic leukeima.
- Studying Childhood ALL Relapse and Survival
(Posted: 04/18/2006) - In this study, researchers will monitor pediatric acute lymphoblastic leukemia patients in different ethnic and racial groups to see if differences can be found in disease biology, in the way cancer-fighting medications (in particular, mercaptopurine) are metabolized by the body, and in adherence to prescribed long-term medication dosing and schedule.